Deguelin inhibits non-small cell lung cancer via down-regulating Hexokinases II-mediated glycolysis.
about
Deguelin induces PUMA-mediated apoptosis and promotes sensitivity of lung cancer cells (LCCs) to doxorubicin (Dox).Butein suppresses hepatocellular carcinoma growth via modulating Aurora B kinase activityAntitumor Ability of KT2 Peptide Derived from Leukocyte Peptide of Crocodile Against Human HCT116 Colon Cancer Xenografts
P2860
Deguelin inhibits non-small cell lung cancer via down-regulating Hexokinases II-mediated glycolysis.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
name
Deguelin inhibits non-small ce ...... inases II-mediated glycolysis.
@ast
Deguelin inhibits non-small ce ...... inases II-mediated glycolysis.
@en
type
label
Deguelin inhibits non-small ce ...... inases II-mediated glycolysis.
@ast
Deguelin inhibits non-small ce ...... inases II-mediated glycolysis.
@en
prefLabel
Deguelin inhibits non-small ce ...... inases II-mediated glycolysis.
@ast
Deguelin inhibits non-small ce ...... inases II-mediated glycolysis.
@en
P2093
P2860
P356
P1433
P1476
Deguelin inhibits non-small ce ...... inases II-mediated glycolysis.
@en
P2093
P2860
P304
32586-32599
P356
10.18632/ONCOTARGET.15937
P407
P577
2017-03-06T00:00:00Z